STOREBRAND ASSET MANAGEMENT AS
Position in RVMD — Revolution Medicines, Inc.
CIK 1685676
LYSAKER, Q8
Position in RVMD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$15,029,407
+$9,839,661 QoQ
Shares Held
80,251
+50.4% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#153
of 688 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STOREBRAND ASSET MANAGEMENT AS holds $199,901,062 across 11 Biotechnology names. RVMD ranks #6 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
107,628 | $53,462,056 | |
| 2 | RPRX |
Royalty Pharma plc
|
703,962 | $39,471,149 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
109,183 | $26,309,827 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,479 | $23,993,195 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
57,580 | $17,333,307 | |
| 6 | RVMD |
Revolution Medicines, Inc.
This page
|
80,251 | $15,029,407 | |
| 7 | INSM |
INSMED Inc
|
124,848 | $13,311,293 | |
| 8 | INCY |
Incyte Corp
|
78,878 | $8,941,610 |
All Filings in RVMD
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,029,407 | 80,251 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $5,189,746 | 53,365 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||